/Companies

▶︎ STRM.BIO

Founded 2019 · 18 employees on LinkedIn · 9 known investors

Find your way into ▶︎ STRM.BIO

Sign up to see every warm intro you have to ▶︎ STRM.BIO

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ▶︎ STRM.BIO team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.

Founders & leadership

MLMichael Luther
Michael LutherCEOMichael Luther has held executive roles across life science operations, from early-stage companies to multinational pharmaceutical and contract research organizations, with international management experience across the UK, Canada, Japan, and India. His background spans drug discovery and development, particularly in oncology and immunology, along with strategic planning, business development, and board governance in public, private, and academic institutions.

Investors · 9

Founder mafia

2 people who came through ▶︎ STRM.BIO went on to found or lead other companies.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2.1M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does ▶︎ STRM.BIO do?
STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.
Who are ▶︎ STRM.BIO's investors?
▶︎ STRM.BIO's investors include Ascension Ventures, Breakout Labs, Breakout Ventures, Delos Capital, Gaingels, NYBC Ventures, Boehringer Ingelheim Venture Fund, KdT Ventures and 1 more.